SCHEMBL6700526

SCHEMBL6700526

CC(C)CC(C(=O)Nc1cc(N(C)C)ccc1Cc1ccccc1C(=O)O)c1cccc2ccccc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 2/20 0.64
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
SLC16A3 O15427 1/20 0.39
KDM4E B2RXH2 2/20 0.38
GAA P10253 2/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NOX1 Q9Y5S8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
CYP2C9 P11712 1/20 0.36
HIF1A Q16665 1/20 0.36
ANPEP P15144 1/20 0.36
POLB P06746 2/20 0.36
MIF P14174 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2988584 0.91 PTGER4 (0.57) PTGER4MEN1KMT2ASLC16A3KDM4E
SCHEMBL5353199 0.91 PTGER4 (0.77) PTGER4MEN1KMT2ASLC16A3KDM4E
SCHEMBL6702424 0.89 PTGER4 (0.63) PTGER4MEN1KMT2ASLC16A3KDM4E
SCHEMBL2981099 0.88 PTGER4 (0.61) PTGER4MEN1KMT2ASLC16A3KDM4E
SCHEMBL5354153 0.87 PTGER4 (0.60) PTGER4MEN1KMT2AKDM4EGAA
SCHEMBL2986535 0.87 PTGER4 (0.60) PTGER4MEN1KMT2ASLC16A3KDM4E
SCHEMBL5356145 0.87 PTGER4 (0.60) PTGER4MEN1KMT2ASLC16A3KDM4E
SCHEMBL5353892 0.86 PTGER4 (0.59) PTGER4MEN1KMT2AKDM4EGAA
SCHEMBL5352209 0.86 PTGER4 (0.59) PTGER4MEN1KMT2ASLC16A3KDM4E
SCHEMBL5352243 0.85 PTGER4 (0.58) PTGER4MEN1KMT2ASLC16A3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040002493-A1 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2004-01-01 US claimed
EP-1314719-A1 BENZOIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2003-05-28 EP claimed
US-20040002493-A1 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2004-01-01 US disclosed
EP-1314719-A1 BENZOIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2003-05-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002493-A1 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient PTGER1, PTGER4, PTGES PTGER4 2/4885MEN1 4656/4885KMT2A 3534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.